Sofosbuvir-velpatasvir 400-100 28S
Ended Awarded
- Contract number
- SPE2DB25FVMD7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,747
Award facts
- Contract value 100% obligated
- $12,746.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,746.52 to AmerisourceBergen Drug Corp for the supply of Sofosbuvir-Velpatasvir 400-100 (28-count), a combination antiviral medication used in hepatitis C treatment. Issued on September 23, 2025, with an ultimate completion date of September 24, 2025, this firm fixed-price contract represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.999 billion prime vendor agreement running through December 2026 that authorizes the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally.
As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen Drug Corp fulfills diverse medical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its comprehensive DLA contract vehicle. The company's federal contract portfolio demonstrates extensive experience delivering brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The rapid completion timeline for this delivery order reflects the urgent medical supply requirements typical of military healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FVMD7?
SPE2DB25FVMD7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 23, 2025.
How much is contract SPE2DB25FVMD7 worth?
The government has obligated $12,747 on SPE2DB25FVMD7.
Is contract SPE2DB25FVMD7 an order under another contract?
Yes. SPE2DB25FVMD7 is a delivery order under SPE2DB22D1202, an indefinite delivery contract.
Was contract SPE2DB25FVMD7 competed?
The extent of competition for SPE2DB25FVMD7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award